个人简介
徐蕴汶，副研究员，博士生导师，在美国约翰霍普金斯大学获得流行病学硕士和博士学位并完成博士后训练。获国家高层次青年人才、上海高层次青年人才、美国糖尿病协会青年研究员奖、美国肾脏病学会肾脏病之星奖等人才项目和荣誉。主要研究方向为心血管代谢性疾病流行病学。在国际学术期刊发表SCI论文40余篇，其中以第一作者（含共同第一作者）身份在Nature Medicine、Circulation、Annals of Internal Medicine等高影响力期刊发表多篇论文，多项成果被全球改善肾脏病预后组织诊治指南、欧洲肾脏最佳实践指南及欧洲高血压学会指南等五项国际指南引用。
教学工作
研究生课程《流行病学I》、本科生课程《流行病学》、“IntMedEdu”国际教育项目（英文授课）
近期10篇代表性成果
# indicates co-first or co-last authors.
1. Xu Y, Malek ND, Chang AR, Echouffo-Tcheugui JB, Selvin E, Grams ME, Fang M, Shin JI. Glucagon-like peptide-1 receptor agonists for major cardiovascular and kidney outcomes in type 1 diabetes. Nat Med. 2026 Mar 19. doi: 10.1038/s41591-026-04274-0. Epub ahead of print. PMID: 41857198.
2. Xu Y, Chang AR, Inker LA, McAdams-DeMarco M, Grams ME, Shin JI. Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease. Circulation. 2023 Nov 7;148(19):1445-1454.
3. Xu Y, Shin JI, Wallace A, Carrero JJ, Inker LA, Mukhopadhyay A, Blecker SB, Horwitz LI, Grams ME, Chang AR. Shortfalls in Follow-up Albuminuria Quantification After an Abnormal Result on a Urine Protein Dipstick Test. Ann Intern Med. 2024 Nov;177(11):1593-1595.
4. Xu Y, Carrero JJ, Chang AR, Inker LA, Zhang D, Mukhopadhyay A, Blecker SB, Horwitz LI, Grams ME, Shin JI. Titration and Discontinuation of Semaglutide for Weight Management in Commercially Insured US Adults. Obesity (Silver Spring). 2025 Jul;33(7):1243-1248.
5. Xu Y, Echouffo Tcheugui JB, Coresh J, Grams ME, Selvin E, Fang M, Shin JI. Trends in Obesity and Glucagon-Like Peptide-1 Receptor Agonist Prescriptions in Type 1 Diabetes in the United States. Diabetes Obes Metab. 2025 Jun;27(6):2967-2976.
6. Xu Y, Ballew SH, Chang AR, Inker LA, Grams ME, Shin JI. Risk of Major Bleeding, Stroke/Systemic Embolism, and Death Associated With Different Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease. J Am Heart Assoc. 2024 Aug 20;13(16):e034641.
7. Xu Y, Boyle TA, Lyu B, Ballew SH, Selvin E, Chang AR, Inker LA, Grams ME, Shin JI. Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Atrial Fibrillation in Adults With Diabetes: A Real-World Study. J Gen Intern Med. 2024 May;39(7):1112-1121.
8. Sandokji I#, Xu Y#, Denburg M, Furth S, Abraham AG#, Greenberg JH#. Current and Novel Biomarkers of Progression Risk in Children With Chronic Kidney Disease. Nephron. 2024;148(1):1-10.
9. Xu Y, Chang AR, Inker LA, McAdams-DeMarco M, Grams ME, Shin JI. Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation. J Am Heart Assoc. 2022 Jul 19;11(14):e025723.
10. Bosi A#, Xu Y#, Gasparini A, Wettermark B, Barany P, Bellocco R, Inker LA, Chang AR, McAdams-DeMarco M, Grams ME, Shin JI#, Carrero JJ#. Use of Nephrotoxic Medications in Adults With Chronic Kidney Disease in Swedish and US Routine Care. Clin Kidney J. 2021 Oct 29;15(3):442-451.
